comparemela.com

Latest Breaking News On - Antifungal resistance - Page 1 : comparemela.com

DNA Explainer: Know why deadly fungal infection Candida auris is scaring people in US?

Candida auris, discovered in Japan in 2009, has seen a concerning rise in the United States, with a 94 per cent increase in cases between 2020 and 2021.

Japan
Kindred-hospital-seattle
Washington
United-states
Candida-auris
Ashington-state-outbreak
Fungal-infection
Kindred-hospital-seattle
Public-health
Healthcare-associated-infections
Antifungal-resistance

There's Been a Staggering Increase in People Killed by Fungi Every Year, Study Finds

The global burden and death toll of fungi has substantially climbed over the past decade, new research finds. The study estimates that fungal infections help kill nearly 4 million people annually—almost double the amount estimated by similar research in 2012. Co-infections like HIV and tuberculosis, a lack of speedy and reliable diagnostic testing, and growing antifungal resistance are thought to be major contributors to these deaths.

Manchester
United-kingdom
David-denning
Instagram
Facebook
Twitter
University-of-manchester
Fungal-infections
David-denning
Aspergillus-mold
University-of-manchester
Tuberculosis-infection

The rise of invasive fungal infections explained

Modern medical technology has saved millions of lives. It has also caused a little-known problem: rising invasive fungal infections. What you need to know. | Health

Hindustan
India-general
India
Zulfikar-abbany
Oliver-cornely
European-center
Agriculture-organization
World-health-organization
Invasive-fungal-infections
United-nations-food
Hindustan-times
Whatsapp-channels

SCYNEXIS Presents New Preclinical Data on Second Generation Fungerp SCY-247 at the 11th Congress on Trends in Medical Mycology (TIMM)

JERSEY CITY, N.J., Oct. 24, 2023 (GLOBE NEWSWIRE) SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the presentation of preclinical data on its second generation fungerp candidate, SCY-247, against a broad panel of fungal pathogens. The analyses were presented by Mahmoud Ghannoum, Ph.D, Professor and Director Center for Medical Mycology, Case Western Reserve Universit

Austria
Jersey
Mahmoud-ghannoum
Martin-hoenigl
Irina-koffler
Case-western-reserve-university
European-confederation-of-medical-mycology
Nasdaq
Scynexis-inc
Drug-administration
Globe-newswire-scynexis-inc
Congress-on-trends-in-medical-mycology

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.